Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 case study

At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 case study is a Harvard Business School (HBR) case study written by Pierre Chandon, Olivier Kovarski, Jacques Lendrevie, Sarah Spargo. The Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 (referred as “Augmentin Clamoxyl” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, Pricing.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment

---

Case Description of Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 Case Study

In July 1996, the French social security governmental agency (the CNAM) sent a letter to all doctors urging them to prescribe generic amoxicillin instead of Clamoxyl, SmithKline Beecham's (SB) blockbuster antibiotic. Pierre Chahwakilian, Marketing Director of SB in France must decide how to respond: (1) milk Clamoxyl and divert promotional investments towards Augmentin, a more specialized and still patent-protected antibiotic, (2) strengthen Clamoxyl's brand equity among doctors by increasing the effort of medical reps, by launching new forms, or with new advertising, (3) go against SB's corporate philosophy and reduce the price of Clamoxyl, or (4) change nothing and count on the resistance of French doctors towards generics. The B case (Augmentin in 2002) shows that GSK (the company formed by the merger of Glaxo Wellcome and SmithKline Beecham) now faces the same options for Augmentin, another blockbuster antibiotic. Should they use the strategy that was so successful for Clamoxyl or have the market conditions changed so much that a whole different approach should be followed?

Case Authors : Pierre Chandon, Olivier Kovarski, Jacques Lendrevie, Sarah Spargo

Topic : Sales & Marketing

Related Areas : Pricing

---

Calculating Net Present Value (NPV) at 6% for Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 Case Study

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 6 %	Discounted Cash Flows
Year 0	(10001846)	-10001846	-	-
Year 1	3472721	-6529125	3472721	0.9434	3276152
Year 2	3953835	-2575290	7426556	0.89	3518899
Year 3	3968166	1392876	11394722	0.8396	3331749
Year 4	3224239	4617115	14618961	0.7921	2553899
TOTAL			14618961		12680699

The Net Present Value at 6% discount rate is 2678853

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting

What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.

---

Capital Budgeting Approaches

Methods of Capital Budgeting

There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Payback Period
3. Net Present Value
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Augmentin Clamoxyl shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Augmentin Clamoxyl have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.

---

Formula and Steps to Calculate Net Present Value (NPV) of Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Augmentin Clamoxyl often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Augmentin Clamoxyl needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 15 %	Discounted Cash Flows
Year 0	(10001846)	-10001846	-	-
Year 1	3472721	-6529125	3472721	0.8696	3019757
Year 2	3953835	-2575290	7426556	0.7561	2989667
Year 3	3968166	1392876	11394722	0.6575	2609134
Year 4	3224239	4617115	14618961	0.5718	1843469
TOTAL					10462027

The Net NPV after 4 years is 460181

(10462027 - 10001846 )

---

Calculating Net Present Value (NPV) at 20%

If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years	Cash Flow	Net Cash Flow	Cumulative     Cash Flow	Discount Rate @ 20 %	Discounted Cash Flows
Year 0	(10001846)	-10001846	-	-
Year 1	3472721	-6529125	3472721	0.8333	2893934
Year 2	3953835	-2575290	7426556	0.6944	2745719
Year 3	3968166	1392876	11394722	0.5787	2296392
Year 4	3224239	4617115	14618961	0.4823	1554899
TOTAL					9490944

The Net NPV after 4 years is -510902

At 20% discount rate the NPV is negative (9490944 - 10001846 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Augmentin Clamoxyl to discount cash flow at lower discount rates such as 15%.

Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Augmentin Clamoxyl has a NPV value higher than Zero then finance managers at Augmentin Clamoxyl can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Augmentin Clamoxyl, then the stock price of the Augmentin Clamoxyl should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Augmentin Clamoxyl should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

What will be a multi year spillover effect of various taxation regulations.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.

---

Negotiation Strategy of Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002

References & Further Readings

Pierre Chandon, Olivier Kovarski, Jacques Lendrevie, Sarah Spargo (2018), "Marketing Strategies in the Competition between Branded and Generic Antibiotics (B): Augmentin in 2002 Harvard Business Review Case Study. Published by HBR Publications.